Hair loss research is advancing rapidly, with scientists exploring treatments that go far beyond the conventional minoxidil and finasteride. Hair Loss Treatment in Riyadh From stem cell therapies to exosome-based serums, the field is shifting toward regenerative approaches that aim to restore follicle function rather than just slow down hair loss. Recent clinical trials are offering some of the most compelling evidence yet for these emerging therapies.

The Current Gold Standard: What Still Works

Before diving into new treatments, it is worth understanding where standard therapies stand. A 2025 network meta-analysis of 24 trials confirmed that conventional treatments remain effective, but they are not equal . Among topical over-the-counter options, 5% topical minoxidil applied twice daily was the most effective . Oral finasteride and dutasteride also showed strong efficacy, though they come with well-documented side effect concerns that drive many patients to seek alternatives .

For acute shedding conditions like telogen effluvium, a 2025 open-label trial found that 5% topical minoxidil significantly increased terminal hair count—by 12.55 hairs per cm² at week 4—and nearly 70% of participants saw a reduction of at least 100 shed hairs . However, the study noted that telogen effluvium is often self-limiting, meaning the natural course of the condition may have contributed to improvement .

Exosomes: The Next Frontier

One of the most promising areas of current research involves exosome-based therapies. These tiny vesicles act as intercellular messengers, carrying proteins, lipids, and nucleic acids that can stimulate hair follicle regeneration .

A 2025 double-blind, placebo-controlled study tested a topical serum containing human platelet exosome extract (HPE) in 39 participants with thinning hair . The results were statistically significant: at 3 and 6 months, the HPE group showed improvements over placebo in hair density, scalp coverage, and volume/fullness (all p < 0.0001) . Participants also reported significant improvements across 11 hair health parameters, including thickness, strength, and overall hair health. No adverse events were observed .

A 2026 systematic review of 11 clinical studies found that mesenchymal stem cell (MSC)-derived exosomes increased hair density by 9.5 to 35 hairs per cm² and hair thickness by up to 13.01 µm . Patient satisfaction was generally high, and no serious adverse events were reported. The strongest evidence came from RCTs using adipose-derived exosome formulations .

Another 2026 study took a different approach: researchers engineered TGF-β-enriched exosomes and delivered them via dissolving microneedles . In a DHT-induced mouse model, this combination increased the proportion of anagen (growth-phase) hair follicles and upregulated hair follicle stem cell markers . The treatment also increased hair follicle count by 50.2% . The authors noted that this minimally invasive strategy could offer a targeted alternative to finasteride with fewer systemic side effects .

PRP and Microneedling: Refining Established Approaches

Platelet-rich plasma (PRP) continues to generate clinical interest, with newer studies comparing delivery methods. A 2025 Phase I trial of 21 AGA patients found that both PRP injections and PRP with microneedling significantly improved hair count and thickness . Hair count increased from 17.4 to 28.26 per cm² with PRP injections, and from 14.71 to 27.71 with microneedling . While the microneedling group showed greater improvement in hair count, the difference was not statistically significant . Patient satisfaction was higher in the microneedling group (69% rating results as "excellent") compared to the injection group (58%) .

A 2025 systematic review of regenerative therapies for AGA found that platelet-rich fibrin (PRF) demonstrated the fastest and most consistent responses, with 62–97% improvements in hair density within 3–6 months . The review also noted that conditioned media from stem cells, when combined with minoxidil, increased hair count by up to 85% .

Natural Alternatives: What the Evidence Says

The same 2025 network meta-analysis that confirmed minoxidil's efficacy also evaluated non-conventional over-the-counter options. It found that topical melatonin and rosemary oil showed some efficacy compared to conventional treatments, though the evidence was less robust . A separate review highlighted that natural oils like rosemary and pumpkin seed oil may support hair regrowth through anti-inflammatory and hormonal modulation effects, but the authors emphasised that standardised, long-term clinical trials are still needed .

What This Means for You

The research landscape is encouraging but still evolving. Exosome-based therapies and regenerative approaches are producing some of the most impressive clinical data to date, with strong safety profiles and meaningful improvements in hair density and quality. However, many of these treatments remain investigational and are not yet widely available.

For those seeking established options, 5% topical minoxidil and PRP (particularly with microneedling) have the strongest current evidence. The choice of treatment should be guided by your specific type of hair loss, your tolerance for side effects, and your willingness to commit to ongoing therapy.

For those seeking expert guidance and customised care, you can book an appointment consultation at the Enfield Royal Clinic.

Frequently Asked Questions

Do exosome treatments really work for hair loss?

Yes, recent clinical trials show topical exosome serums significantly improve hair density, thickness, and scalp coverage with no adverse effects. Results are promising but still emerging.

Is PRP or microneedling better for hair regrowth?

Both improve hair count and thickness significantly. Microneedling tends to have higher patient satisfaction and less discomfort, but the difference in efficacy is not statistically significant.

Are natural oils like rosemary effective for hair loss?

Rosemary oil and melatonin have shown some efficacy in clinical trials, but the evidence is less robust than for minoxidil. They may be options for those who cannot tolerate conventional treatments.

How long does it take to see results from minoxidil?

For telogen effluvium, improvements in terminal hair count were observed as early as 4 weeks. For pattern baldness, visible results typically take 3–6 months of consistent use.

Are exosome treatments safe?

Current evidence shows no serious adverse events. Topical exosome serums have been well-tolerated in clinical trials, with no reported side effects.

Metabolic health—the ability of the body to regulate blood sugar, lipid levels, and energy balance—is foundational to long-term wellness. Peptide Treatment in Riyadh When these systems are disrupted, the consequences can affect every organ in the body. Peptide-based interventions are emerging as a promising area of research for supporting metabolic health, offering mechanisms that go beyond simple appetite suppression to influence insulin sensitivity, inflammation, and cellular energy regulation.

How Peptides Influence Insulin Sensitivity

The current evidence suggests that bioactive peptides work through multiple pathways to improve metabolic health. A 2025 mechanistic review published in ScienceDirect found that food-derived peptides can enhance insulin sensitivity by activating the IRS-1/PI3K/Akt pathway and facilitating AMPK-mediated GLUT4 translocation, which is essential for glucose uptake in muscle and adipose tissue . The same review noted that peptides can also influence incretin hormones through calcium-sensing receptor-dependent GLP-1 secretion and inhibit digestive enzymes like α-amylase and α-glucosidase . These mechanisms position bioactive peptides as promising nutraceutical candidates for managing conditions like type 2 diabetes and obesity .

Recent studies have provided more specific evidence of peptide efficacy. A 2025 study on rice protein-derived peptides (IQP, VEP, and IPQ) demonstrated that supplementation in high-fat diet-induced obese mice significantly alleviated white adipose accumulation, hyperglycemia, insulin resistance, hepatic steatosis, and chronic inflammation over seven weeks . The peptides worked through activation of AMPK in skeletal muscle and modulation of gut microbiota, including beneficial genera like Akkermansia . Similarly, wheat peptides (LPQ and LPQF) showed dose-dependent attenuation of weight gain, fasting hyperglycemia, and insulin resistance in a 2025 study, with effects linked to DPP-IV inhibition, suppression of systemic inflammation, and restoration of metabolic homeostasis .

Collagen Peptides and Metabolic Function

Collagen peptides, often associated with joint and skin health, have also demonstrated metabolic benefits. A 2025 study on a type 2 diabetes mouse model found that collagen peptide administration (400 mg/kg/day for 4 weeks) significantly reduced blood glucose and lipid levels, increased serum GLP-1 levels, and decreased the insulin resistance index . The mechanism involved upregulation of IRS1, activation of AMPK, and modulation of gut microbiota, with increased short-chain fatty acid concentrations . These findings suggest that collagen peptides may offer a food-derived alternative to synthetic DPP-IV inhibitors for managing hyperglycemia .

Mitochondrial-Derived Peptides and Diabetes Prevention

A particularly notable area of research involves mitochondrial-derived peptides (MDPs). A 2026 study published in Peptides investigated humanin, MOTS-c, and SHLP2 in a high-fat diet/streptozotocin-induced mouse model of type 2 diabetes . The researchers found that MDP administration delayed diabetes onset, as evidenced by a lower diabetes induction rate, and mitigated alterations in body weight, HbA1c, glucose homeostasis, insulin resistance, and pancreatic islet cell dysfunction . Notably, the combined MDP treatment group exhibited the most significant therapeutic effects at six weeks post-administration . The authors concluded that these peptides show promise for preventing or delaying the progression from prediabetes to diabetes .

A Note on Clinical Translation and Availability

While the preclinical evidence for peptide-based metabolic interventions is promising, it is important to note that most of the research discussed here has been conducted in animal models. Some peptides, such as MD-18, a first-in-class PTP1B-targeting peptide, have progressed to Phase 1b clinical trials, demonstrating 2.7% weight loss and improvements in insulin measures and LDL cholesterol while preserving lean muscle mass . However, many of the compounds studied are not currently available as prescription therapies for metabolic health and should not be confused with over-the-counter supplements or unregulated peptide products.

The Importance of Professional Guidance

Metabolic health is complex, and individual needs vary. For those considering peptide-based interventions, professional supervision is essential. A qualified provider can assess your health history, baseline biomarkers, and goals to determine whether peptide therapy is appropriate and which compounds may be most suitable. This ensures both safety and the best chance of achieving meaningful outcomes.

For those seeking expert guidance and customized metabolic health support, you can book an appointment consultation at the Enfield Royal Clinic.